LATEST

• REGULATORY DMD Gene Therapy Elevidys Cleared for NHI Listing at 305 Million Yen
  February 13, 2026

• BUSINESS FRONTEO to Back Biotech Startups with AI and Capital as Third Biz Leg
  February 13, 2026

• BUSINESS Biomedix Takes Over Originator Data as Generics Face Supply, Information Challenge
  February 13, 2026

• BUSINESS Datroway Filed for 1st-Line TNBC in Japan: Daiichi Sankyo
  February 13, 2026

• BUSINESS Nxera Gets US$1.8 Million Early-Stage Milestone from Centessa
  February 13, 2026

• BUSINESS Nxera Licenses GPCR Program to European VC-Backed Startup
  February 13, 2026

• BUSINESS Alfresa Launches Neffy Nasal Spray for Anaphylaxis in Japan
  February 13, 2026

• BUSINESS Teijin Seeks Japan Nod for Ascendis’s GHD Drug
  February 13, 2026

• REGULATORY MHLW Orders Label Revisions for Vyxeos, Inlyta, Imbruvica, and More Drugs
  February 13, 2026

• REGULATORY MHLW Orders Label Revisions for Sulfite-Containing Medical Products
  February 13, 2026

• BUSINESS Novo Targets Double-Digit Growth in Japan in 2026, Obesity Access Key
  February 12, 2026

• BUSINESS Takeda’s Narcolepsy Drug Accepted for US FDA Review
  February 12, 2026

• BUSINESS FDA Rejects Regenxbio/Nippon Shinyaku’s MPS II Gene Therapy
  February 12, 2026

• BUSINESS Celltrion to Launch Japan’s First Actemra Biosimilar in Late April
  February 12, 2026

• REGULATORY PMDA Urges Proper Use of Colchicine, Advises against High-Dose Administration
  February 12, 2026

• REGULATORY PMDA to Offer Priority Consultations for Overseas Startups
  February 12, 2026

• REGULATORY Japan OKs 2nd OTC Emergency Contraceptive, Launch Set for March 9
  February 12, 2026

• BUSINESS MFN Policy Could Affect Business Outside US: Kyowa Kirin CEO
  February 12, 2026

• BUSINESS Kyowa Kirin Aims to Raise Core Margin to 30% on Late-Stage Launches
  February 12, 2026

• BUSINESS Chugai Exercises Option to Develop Multi-Payload ADCs with Araris
  February 12, 2026

ページ

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »